INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Consolidated Net Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|
What is the latest Consolidated Net Profit of INDO US BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹8.11 |
| Mar2024 | ₹4.12 |
| Mar2023 | ₹3.61 |
| Mar2022 | ₹2.86 |
| Mar2021 | ₹3.50 |
How is Consolidated Net Profit of INDO US BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.11 | 0 | |
| Mar2024 | ₹4.12 | 0 | |
| Mar2023 | ₹3.61 | 0 | |
| Mar2022 | ₹2.86 | 0 | |
| Mar2021 | ₹3.50 | - | |
Compare Consolidated Net Profit of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹297.3 Cr | 2.5% | 25% | -31.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,411.4 Cr | -1.6% | 2.6% | -6.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,241.2 Cr | -2.1% | 0.8% | -16.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,951.1 Cr | -2.5% | -6.3% | -17.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹956.9 Cr | -0.8% | -2% | -34.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹385.3 Cr | -1.9% | -4.8% | -3.4% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 2.5% |
25% |
-31.9% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses